Correction to: Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose control

Johanne Tremblay, M. Haloui, Redha Attaoua, Ramzan Tahir, Camil Hishmih, F. Harvey, Francois Christophe Marois-Blanchet, Carole Long, Paul H.G. Simon, Lara Santucci, Candan Hizel, J. Chalmers, Michel Marre, Stephen Harrap, R. Cífková, Alena Krajčoviechová, David R. Matthews, Bryan Williams, Neil Poulter, Sophia ZoungasS. Colagiuri, Giuseppe Mancia, Diederick E. Grobbee, Anthony Rodgers, Liusheng Liu, Mawussé Agbessi, Vanessa Bruat, Marie-Julie Favé, Michelle P. Harwood, P. Awadalla, Mark Woodward, Julie G. Hussin, Pavel Hamet

Research output: Contribution to journalComment/debate

Abstract

The authors regret that they omitted to acknowledge the clinical and organisational assistance of M.-R. Guertin and P. Dumas (CRCHUM and Medpharmgene, Montreal, Québec, Canada) in the ADVANCE and CLINPRADIA studies. The original article has been corrected.

Original languageEnglish
Pages (from-to)2355-2356
Number of pages2
JournalDiabetologia
Volume64
Issue number10
DOIs
Publication statusPublished - Oct 2021
Externally publishedYes

Keywords

  • ADVANCE trial
  • Cardiovascular complications
  • Genetics
  • Polygenic risk score
  • Prediction
  • Renal complications
  • UK Biobank

Fingerprint

Dive into the research topics of 'Correction to: Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose control'. Together they form a unique fingerprint.

Cite this